Page last updated: 2024-09-04

win 64338 and cyclic gmp

win 64338 has been researched along with cyclic gmp in 2 studies

Compound Research Comparison

Studies
(win 64338)
Trials
(win 64338)
Recent Studies (post-2010)
(win 64338)
Studies
(cyclic gmp)
Trials
(cyclic gmp)
Recent Studies (post-2010) (cyclic gmp)
190222,3463334,062

Protein Interaction Comparison

ProteinTaxonomywin 64338 (IC50)cyclic gmp (IC50)
Phosphodiesterase Bos taurus (cattle)0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)2.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.4

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schölkens, BA; Wiemer, G; Wirth, KJ1
Dedio, J; Schölkens, BA; Wiemer, G; Wirth, K; Wohlfart, P1

Other Studies

2 other study(ies) available for win 64338 and cyclic gmp

ArticleYear
The bradykinin B2 receptor antagonist WIN 64338 inhibits the effect of des-Arg9-bradykinin in endothelial cells.
    European journal of pharmacology, 1994, Dec-15, Volume: 288, Issue:1

    Topics: Animals; Aorta; Binding, Competitive; Bradykinin; Bradykinin Receptor Antagonists; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Naphthalenes; Nitric Oxide; Organophosphorus Compounds; Rabbits

1994
Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:2

    Topics: Animals; Aorta; Bradykinin; Bradykinin Receptor Antagonists; Cattle; Cells, Cultured; Coronary Vessels; Cyclic GMP; DNA Primers; Endothelium, Vascular; Humans; Microcirculation; Naphthalenes; Organophosphorus Compounds; Polymerase Chain Reaction; Rats; Receptor, Bradykinin B1; Receptors, Bradykinin; Species Specificity; Transcription, Genetic; Umbilical Veins

1997